Discontinued — last reported Q2 '21
Amgen Debt - Unamortized Discount (Premium) and Issuance Costs, Net decreased by 1.1% to $1.32B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.1%, from $1.37B to $1.32B. Over 4 years (FY 2020 to FY 2024), Debt - Unamortized Discount (Premium) and Issuance Costs, Net shows an upward trend with a 3.4% CAGR.
Changes reflect the issuance of new debt or the amortization of existing discounts/premiums, impacting future interest expense.
This represents the net adjustment to the face value of debt, accounting for the difference between the issuance price a...
Standard accounting adjustment for any company with significant long-term debt instruments on its balance sheet.
debt_unamortized_discount_premium_issuance_costs| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.17B | $1.22B | $1.21B | $1.25B | $1.25B | $1.25B | $1.25B | $1.43B | $1.44B | $1.42B | $1.42B | $1.40B | $1.39B | $1.37B | $1.36B | $1.35B | $1.33B | $1.32B |
| QoQ Change | — | +4.0% | -0.7% | +3.3% | -0.6% | +0.6% | -0.5% | +15.1% | +0.3% | -1.0% | -0.2% | -1.1% | -1.1% | -1.2% | -0.9% | -1.1% | -1.0% | -1.1% |
| YoY Change | — | — | — | — | +6.0% | +2.5% | +2.7% | +14.4% | +15.5% | +13.7% | +14.0% | -2.1% | -3.4% | -3.5% | -4.2% | -4.2% | -4.2% | -4.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.